Gene expression signatures in lymph node cells play an active role in lymphoma development

Researchers from the University of Tsukuba identify gene expression signatures in different types of lymph nodes cells that play an active role in the development of lymphomas.

Lymphomas are blood cancers that often start from lymph nodes. Lymph nodes contain not only hematopoietic cells, mainly B- and T-lymphoid cells, but also non-hematopoietic cells (NHCs), also called stromal cells. We know from previous research that NHCs have an active role in the development of lymphomas. However, it is still not clear how they promote the expansion and proliferation of lymphomas. Despite advancement in therapeutic options, most lymphomas remain uncurable.

In a paper published in Nature Cell Biology in March 2022, researchers from the University of Tsukuba constructed an atlas of more than 100,000 NHCs collected from 27 human samples, encompassing different types of lymphomas such as follicular lymphomas. The research team used single-cell RNA sequencing to profile the gene expression of the hundreds of thousands of NHCs. On the basis of this expression, the researchers divided them into different subgroups, called clusters, and discovered a significant heterogeneity of these cells. The researchers observed that this heterogeneity was detectable also in aggressive lymphomas, meaning that some of these subgroups could be involved in the progression of the tumor. They identified several subgroups of NHCs, including some that were previously unrecognized - for example, specific types of endothelial cells.

Once the atlas was developed, we performed differential gene expression analysis between subgroups in different types of lymph nodes affected by lymphoma, and interestingly we found subcluster-specific transcriptional changes and a specific pattern of interaction with malignant cells in the stroma of follicular lymphomas."

Professor Mamiko Sakata-Yanagimoto, lead author of the study

Follicular lymphomas are one of the most common types of lymphoma. Therefore, having a gene expression signature and a prediction of how NHCs can interact with malignant cells may be very useful to keep the tumor development under control, as they suggest potential biomarkers for therapeutic approaches.

Another important finding of the study suggested that human lymph nodes have unique NHC subpopulations that have not been previously detected in mouse lymph nodes. This highlights the importance of carrying out more human studies in the future.

Professor Mamiko Sakata-Yanagimoto summarized the contribution of this research by noting its potential for therapeutic applications globally: "This single-cell atlas of NHCs in human lymph nodes that we developed is applicable to lymphoma researchers all around the world. It can provide deep insights into lymphoma stromal biology and resources applicable to future studies on lymphomas, and also identify potential stroma-derived biomarkers that may serve as clinical indicators and/or therapeutic targets".

Journal reference:

Abe, Y., et al. (2022) A single-cell atlas of non-hematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodeling. Nature Cell Biology.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Safer and More Effective Cell Therapy for Spinal Cord Injuries